The most-read gene therapy articles included topics on FDA approvals, chimeric antigen receptor T-cell therapies, the ...

The majority of SCD patients given Lyfgenia in clinical trials remained free of vaso-occlusive events (VOEs) following ...

Jefferies upgrades Vertex Pharmaceuticals to Buy, highlighting a promising pipeline and $5 billion-$7 billion growth ...